Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor

Neurocutaneous melanosis (NCM) is a rare congenital disorder characterized by the association of large and/or multiple congenital melanocytic nevi (CMN) of the skin with melanocytic lesions of the leptomeninges, including melanocytosis. Leptomeningeal melanocytosis carries a poor prognosis once neur...

Descripción completa

Detalles Bibliográficos
Autores principales: Küsters-Vandevelde, Heidi VN, Willemsen, Annelieke ECAB, Groenen, Patricia JTA, Küsters, Benno, Lammens, Martin, Wesseling, Pieter, Djafarihamedani, Melika, Rijntjes, Jos, Delye, Hans, Willemsen, Michel A, van Herpen, Carla ML, Blokx, Willeke AM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023633/
https://www.ncbi.nlm.nih.gov/pubmed/24713450
http://dx.doi.org/10.1186/2051-5960-2-41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023633/
https://www.ncbi.nlm.nih.gov/pubmed/24713450
http://dx.doi.org/10.1186/2051-5960-2-41

Ejemplares similares